The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational update & presentation published online

24 Oct 2016 07:00

RNS Number : 2051N
InnovaDerma PLC
24 October 2016
 

 

InnovaDerma PLC ("InnovaDerma", the "Company" or the "Group")

Operational Update & Notice of Presentation Published on Website

 

InnovaDerma, a UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, is pleased to provide an operational update, and to announce that its corporate presentation is available for viewing within the Investor Relations section of the Company's website: http://www.innovaderma.com/investor-relations/

 

Production move to the UK

 

The Company has been supplying the worldwide markets with its products from an Australian based manufacturer since inception. As a result of its ongoing expansion plans in the UK and Europe, and in addition to the success of Skinny Tan in Superdrug's stores nationwide, the Board is pleased to announce that it will be moving a significant part of its production to the UK, from Australia.

Prestige Personal Care Ltd (HMC Health & Beauty), a leading skincare and haircare manufacturer, has been appointed to undertake production of InnovaDerma's products, which will initially be distributed to the UK market but with plans to extend this to other global markets. Production in the UK is expected to begin in December 2016.

The production move to the UK will significantly improve the Company's supply chain to its most important growth markets and key customers. The Board expects a notable improvement in the operating margins of the business as a result of lower freight and logistics costs and minimized currency exchange exposure. The cost benefits are expected to positively impact the Company's financial performance from the second half of the financial year 2017.

 

Haris Chaudhry, Executive Chairman said:

"Our strategic decision to move part of our production to the UK was driven by two things: the importance InnovaDerma places on this market, and the savings to be found, principally in the areas of manufacturing and logistics. The subsequent depreciation in the pound sterling has made the UK an even more competitive place from which to do business, and more attractive to investors, which lends further weight to the Board's decision to grow both in this market and elsewhere in Europe."

 

Further enquiries:

InnovaDerma

Haris Chaudhry/Joe Bayer

 

 

+61 (0)3 9111 0071

Sole broker

Hybridan LLP

Claire Noyce

 

 

+44 (0)203 764 2341

Cardew Group

Shan Shan Willenbrock

David Roach

Emma Ruttle

 

+ 44 (0)20 7930 0777

 

About InnovaDerma:

InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

www.innovaderma.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDLFLFLQBFZFBB
Date   Source Headline
5th May 20172:05 pmRNSSecond Price Monitoring Extn
5th May 20172:00 pmRNSPrice Monitoring Extension
3rd May 20172:06 pmRNSSecond Price Monitoring Extn
3rd May 20172:00 pmRNSPrice Monitoring Extension
3rd May 20177:15 amRNSCompany update and Directorate Change
2nd May 20177:00 amRNSAcquisition
28th Apr 20178:05 amRNSBroker Warrants
11th Apr 20177:00 amRNSAllotment of Shares
3rd Apr 20177:00 amRNSTrading update
3rd Mar 20174:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20174:35 pmRNSPrice Monitoring Extension
3rd Mar 20172:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20172:00 pmRNSPrice Monitoring Extension
2nd Mar 201711:18 amRNSExercise of Share Options
1st Mar 20177:00 amRNSCompletion of Acquisitions
27th Feb 20177:00 amRNSAcquisition of Stevie K and Charles + Lee Brands
9th Feb 20177:00 amRNSHalf-year Report
30th Jan 20177:00 amRNSDirectorate Change
27th Jan 201711:17 amRNSNotice of Results
25th Jan 20178:00 amRNSHeads of Agreement with PROS Korea
16th Jan 20177:00 amRNSTrading Statement
10th Jan 20177:00 amRNSDirectorate Change
9th Jan 20179:06 amRNSSecond Price Monitoring Extn
9th Jan 20179:00 amRNSPrice Monitoring Extension
19th Dec 20163:18 pmRNSHolding(s) in Company
15th Dec 201610:08 amRNSResult of AGM
14th Dec 20169:45 amRNSPlacing
8th Dec 20167:00 amRNSCompletion of Placing
6th Dec 20167:30 amRNSGeneral Manager appointed for the UK and Europe
25th Nov 20167:00 amRNSPlacing and Fundraising
17th Nov 20164:34 pmRNSNotice of AGM & Posting of Annual Report
16th Nov 20161:54 pmRNSBroker Warrants
14th Nov 20167:00 amRNSPublication of Supplementary Prospectus
11th Nov 201611:23 amRNSDirector/PDMR Shareholding
31st Oct 201610:25 amRNSFinal Results
31st Oct 20167:00 amRNSInnovaDerma enters US market
24th Oct 20167:00 amRNSOperational update & presentation published online
21st Oct 20162:15 pmRNSIssue of Equity
20th Oct 201611:05 amRNSSecond Price Monitoring Extn
20th Oct 201611:00 amRNSPrice Monitoring Extension
10th Oct 20167:00 amRNSTrading Statement
9th Sep 201612:38 pmRNSVoluntary Suspension of Trading on Marche Libre
7th Sep 20167:00 amRNSAdmission to the Official List

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.